TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global Lung Cancer Therapeutics Market Insights, Forecast to 2028

Global Lung Cancer Therapeutics Market Insights, Forecast to 2028

  • Category:Life Sciences
  • Published on : 26 August 2022
  • Pages :106
  • Formats:
  • Report Code:SMR-7300530
OfferClick for best price

Best Price: $3920

Lung Cancer Therapeutics Market Size, Share 2022


Market Analysis and Insights: Global Lung Cancer Therapeutics Market

The global Lung Cancer Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Lung Cancer Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Lung Cancer Therapeutics market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Lung Cancer Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Lung Cancer Therapeutics market.

Global Lung Cancer Therapeutics Scope and Market Size

Lung Cancer Therapeutics market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Lung Cancer Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Targeted Therapy

Immunotherapy

Chemotherapy

Radiation Therapy

Others

Segment by Application

Non-Small Cell Lung Cancer (NSCLC)

Small Cell Lung Cancer (SCLC)

By Company

AstraZeneca

Eli Lilly and Company

GlaxoSmithKline

Roche

Boehringer Ingelheim GmbH

Pfizer

Sanofi S.A.

Bristol-Myers Squibb

Novartis

Agennix AG

By Region

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Lung Cancer Therapeutics product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Lung Cancer Therapeutics, with price, sales, revenue, and global market share of Lung Cancer Therapeutics from 2019 to 2022.

Chapter 3, the Lung Cancer Therapeutics competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Lung Cancer Therapeutics breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Lung Cancer Therapeutics market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Lung Cancer Therapeutics.

Chapter 13, 14, and 15, to describe Lung Cancer Therapeutics sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 Lung Cancer Therapeutics Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes Report Details
Report Title Global Lung Cancer Therapeutics Market Insights, Forecast to 2028
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 106 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lung Cancer Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Targeted Therapy
1.2.3 Immunotherapy
1.2.4 Chemotherapy
1.2.5 Radiation Therapy
1.2.6 Others
1.3 Market by Application
1.3.1 Global Lung Cancer Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Non-Small Cell Lung Cancer (NSCLC)
1.3.3 Small Cell Lung Cancer (SCLC)
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Lung Cancer Therapeutics Market Perspective (2017-2028)
2.2 Lung Cancer Therapeutics Growth Trends by Region
2.2.1 Lung Cancer Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Lung Cancer Therapeutics Historic Market Size by Region (2017-2022)
2.2.3 Lung Cancer Therapeutics Forecasted Market Size by Region (2023-2028)
2.3 Lung Cancer Therapeutics Market Dynamics
2.3.1 Lung Cancer Therapeutics Industry Trends
2.3.2 Lung Cancer Therapeutics Market Drivers
2.3.3 Lung Cancer Therapeutics Market Challenges
2.3.4 Lung Cancer Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Lung Cancer Therapeutics Players by Revenue
3.1.1 Global Top Lung Cancer Therapeutics Players by Revenue (2017-2022)
3.1.2 Global Lung Cancer Therapeutics Revenue Market Share by Players (2017-2022)
3.2 Global Lung Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Lung Cancer Therapeutics Revenue
3.4 Global Lung Cancer Therapeutics Market Concentration Ratio
3.4.1 Global Lung Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lung Cancer Therapeutics Revenue in 2021
3.5 Lung Cancer Therapeutics Key Players Head office and Area Served
3.6 Key Players Lung Cancer Therapeutics Product Solution and Service
3.7 Date of Enter into Lung Cancer Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Lung Cancer Therapeutics Breakdown Data by Type
4.1 Global Lung Cancer Therapeutics Historic Market Size by Type (2017-2022)
4.2 Global Lung Cancer Therapeutics Forecasted Market Size by Type (2023-2028)
5 Lung Cancer Therapeutics Breakdown Data by Application
5.1 Global Lung Cancer Therapeutics Historic Market Size by Application (2017-2022)
5.2 Global Lung Cancer Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Lung Cancer Therapeutics Market Size (2017-2028)
6.2 North America Lung Cancer Therapeutics Market Size by Type
6.2.1 North America Lung Cancer Therapeutics Market Size by Type (2017-2022)
6.2.2 North America Lung Cancer Therapeutics Market Size by Type (2023-2028)
6.2.3 North America Lung Cancer Therapeutics Market Share by Type (2017-2028)
6.3 North America Lung Cancer Therapeutics Market Size by Application
6.3.1 North America Lung Cancer Therapeutics Market Size by Application (2017-2022)
6.3.2 North America Lung Cancer Therapeutics Market Size by Application (2023-2028)
6.3.3 North America Lung Cancer Therapeutics Market Share by Application (2017-2028)
6.4 North America Lung Cancer Therapeutics Market Size by Country
6.4.1 North America Lung Cancer Therapeutics Market Size by Country (2017-2022)
6.4.2 North America Lung Cancer Therapeutics Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Lung Cancer Therapeutics Market Size (2017-2028)
7.2 Europe Lung Cancer Therapeutics Market Size by Type
7.2.1 Europe Lung Cancer Therapeutics Market Size by Type (2017-2022)
7.2.2 Europe Lung Cancer Therapeutics Market Size by Type (2023-2028)
7.2.3 Europe Lung Cancer Therapeutics Market Share by Type (2017-2028)
7.3 Europe Lung Cancer Therapeutics Market Size by Application
7.3.1 Europe Lung Cancer Therapeutics Market Size by Application (2017-2022)
7.3.2 Europe Lung Cancer Therapeutics Market Size by Application (2023-2028)
7.3.3 Europe Lung Cancer Therapeutics Market Share by Application (2017-2028)
7.4 Europe Lung Cancer Therapeutics Market Size by Country
7.4.1 Europe Lung Cancer Therapeutics Market Size by Country (2017-2022)
7.4.2 Europe Lung Cancer Therapeutics Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Lung Cancer Therapeutics Market Size (2017-2028)
8.2 Asia-Pacific Lung Cancer Therapeutics Market Size by Type
8.2.1 Asia-Pacific Lung Cancer Therapeutics Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Lung Cancer Therapeutics Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Lung Cancer Therapeutics Market Share by Type (2017-2028)
8.3 Asia-Pacific Lung Cancer Therapeutics Market Size by Application
8.3.1 Asia-Pacific Lung Cancer Therapeutics Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Lung Cancer Therapeutics Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Lung Cancer Therapeutics Market Share by Application (2017-2028)
8.4 Asia-Pacific Lung Cancer Therapeutics Market Size by Region
8.4.1 Asia-Pacific Lung Cancer Therapeutics Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Lung Cancer Therapeutics Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Lung Cancer Therapeutics Market Size (2017-2028)
9.2 Latin America Lung Cancer Therapeutics Market Size by Type
9.2.1 Latin America Lung Cancer Therapeutics Market Size by Type (2017-2022)
9.2.2 Latin America Lung Cancer Therapeutics Market Size by Type (2023-2028)
9.2.3 Latin America Lung Cancer Therapeutics Market Share by Type (2017-2028)
9.3 Latin America Lung Cancer Therapeutics Market Size by Application
9.3.1 Latin America Lung Cancer Therapeutics Market Size by Application (2017-2022)
9.3.2 Latin America Lung Cancer Therapeutics Market Size by Application (2023-2028)
9.3.3 Latin America Lung Cancer Therapeutics Market Share by Application (2017-2028)
9.4 Latin America Lung Cancer Therapeutics Market Size by Country
9.4.1 Latin America Lung Cancer Therapeutics Market Size by Country (2017-2022)
9.4.2 Latin America Lung Cancer Therapeutics Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Lung Cancer Therapeutics Market Size (2017-2028)
10.2 Middle East & Africa Lung Cancer Therapeutics Market Size by Type
10.2.1 Middle East & Africa Lung Cancer Therapeutics Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Lung Cancer Therapeutics Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Lung Cancer Therapeutics Market Share by Type (2017-2028)
10.3 Middle East & Africa Lung Cancer Therapeutics Market Size by Application
10.3.1 Middle East & Africa Lung Cancer Therapeutics Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Lung Cancer Therapeutics Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Lung Cancer Therapeutics Market Share by Application (2017-2028)
10.4 Middle East & Africa Lung Cancer Therapeutics Market Size by Country
10.4.1 Middle East & Africa Lung Cancer Therapeutics Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Lung Cancer Therapeutics Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Lung Cancer Therapeutics Introduction
11.1.4 AstraZeneca Revenue in Lung Cancer Therapeutics Business (2017-2022)
11.1.5 AstraZeneca Recent Developments
11.2 Eli Lilly and Company
11.2.1 Eli Lilly and Company Company Details
11.2.2 Eli Lilly and Company Business Overview
11.2.3 Eli Lilly and Company Lung Cancer Therapeutics Introduction
11.2.4 Eli Lilly and Company Revenue in Lung Cancer Therapeutics Business (2017-2022)
11.2.5 Eli Lilly and Company Recent Developments
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Lung Cancer Therapeutics Introduction
11.3.4 GlaxoSmithKline Revenue in Lung Cancer Therapeutics Business (2017-2022)
11.3.5 GlaxoSmithKline Recent Developments
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Lung Cancer Therapeutics Introduction
11.4.4 Roche Revenue in Lung Cancer Therapeutics Business (2017-2022)
11.4.5 Roche Recent Developments
11.5 Boehringer Ingelheim GmbH
11.5.1 Boehringer Ingelheim GmbH Company Details
11.5.2 Boehringer Ingelheim GmbH Business Overview
11.5.3 Boehringer Ingelheim GmbH Lung Cancer Therapeutics Introduction
11.5.4 Boehringer Ingelheim GmbH Revenue in Lung Cancer Therapeutics Business (2017-2022)
11.5.5 Boehringer Ingelheim GmbH Recent Developments
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Lung Cancer Therapeutics Introduction
11.6.4 Pfizer Revenue in Lung Cancer Therapeutics Business (2017-2022)
11.6.5 Pfizer Recent Developments
11.7 Sanofi S.A.
11.7.1 Sanofi S.A. Company Details
11.7.2 Sanofi S.A. Business Overview
11.7.3 Sanofi S.A. Lung Cancer Therapeutics Introduction
11.7.4 Sanofi S.A. Revenue in Lung Cancer Therapeutics Business (2017-2022)
11.7.5 Sanofi S.A. Recent Developments
11.8 Bristol-Myers Squibb
11.8.1 Bristol-Myers Squibb Company Details
11.8.2 Bristol-Myers Squibb Business Overview
11.8.3 Bristol-Myers Squibb Lung Cancer Therapeutics Introduction
11.8.4 Bristol-Myers Squibb Revenue in Lung Cancer Therapeutics Business (2017-2022)
11.8.5 Bristol-Myers Squibb Recent Developments
11.9 Novartis
11.9.1 Novartis Company Details
11.9.2 Novartis Business Overview
11.9.3 Novartis Lung Cancer Therapeutics Introduction
11.9.4 Novartis Revenue in Lung Cancer Therapeutics Business (2017-2022)
11.9.5 Novartis Recent Developments
11.10 Agennix AG
11.10.1 Agennix AG Company Details
11.10.2 Agennix AG Business Overview
11.10.3 Agennix AG Lung Cancer Therapeutics Introduction
11.10.4 Agennix AG Revenue in Lung Cancer Therapeutics Business (2017-2022)
11.10.5 Agennix AG Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global Lung Cancer Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Targeted Therapy
Table 3. Key Players of Immunotherapy
Table 4. Key Players of Chemotherapy
Table 5. Key Players of Radiation Therapy
Table 6. Key Players of Others
Table 7. Global Lung Cancer Therapeutics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 8. Global Lung Cancer Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Lung Cancer Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Lung Cancer Therapeutics Market Share by Region (2017-2022)
Table 11. Global Lung Cancer Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Lung Cancer Therapeutics Market Share by Region (2023-2028)
Table 13. Lung Cancer Therapeutics Market Trends
Table 14. Lung Cancer Therapeutics Market Drivers
Table 15. Lung Cancer Therapeutics Market Challenges
Table 16. Lung Cancer Therapeutics Market Restraints
Table 17. Global Lung Cancer Therapeutics Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Lung Cancer Therapeutics Revenue Share by Players (2017-2022)
Table 19. Global Top Lung Cancer Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Therapeutics as of 2021)
Table 20. Ranking of Global Top Lung Cancer Therapeutics Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Lung Cancer Therapeutics Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Lung Cancer Therapeutics Product Solution and Service
Table 24. Date of Enter into Lung Cancer Therapeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Lung Cancer Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Lung Cancer Therapeutics Revenue Market Share by Type (2017-2022)
Table 28. Global Lung Cancer Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Lung Cancer Therapeutics Revenue Market Share by Type (2023-2028)
Table 30. Global Lung Cancer Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Lung Cancer Therapeutics Revenue Share by Application (2017-2022)
Table 32. Global Lung Cancer Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Lung Cancer Therapeutics Revenue Share by Application (2023-2028)
Table 34. North America Lung Cancer Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 35. North America Lung Cancer Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 36. North America Lung Cancer Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 37. North America Lung Cancer Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 38. North America Lung Cancer Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 39. North America Lung Cancer Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 40. Europe Lung Cancer Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 41. Europe Lung Cancer Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 42. Europe Lung Cancer Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 43. Europe Lung Cancer Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 44. Europe Lung Cancer Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 45. Europe Lung Cancer Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 46. Asia Pacific Lung Cancer Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 47. Asia Pacific Lung Cancer Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 48. Asia Pacific Lung Cancer Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 49. Asia Pacific Lung Cancer Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 50. Asia Pacific Lung Cancer Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 51. Asia Pacific Lung Cancer Therapeutics Market Size by Region (2023-2028) & (US$ Million)
Table 52. Latin America Lung Cancer Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 53. Latin America Lung Cancer Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 54. Latin America Lung Cancer Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 55. Latin America Lung Cancer Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 56. Latin America Lung Cancer Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 57. Latin America Lung Cancer Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Lung Cancer Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Lung Cancer Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Lung Cancer Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Lung Cancer Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 62. Middle East and Africa Lung Cancer Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 63. Middle East and Africa Lung Cancer Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 64. AstraZeneca Company Details
Table 65. AstraZeneca Business Overview
Table 66. AstraZeneca Lung Cancer Therapeutics Product
Table 67. AstraZeneca Revenue in Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 68. AstraZeneca Recent Developments
Table 69. Eli Lilly and Company Company Details
Table 70. Eli Lilly and Company Business Overview
Table 71. Eli Lilly and Company Lung Cancer Therapeutics Product
Table 72. Eli Lilly and Company Revenue in Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 73. Eli Lilly and Company Recent Developments
Table 74. GlaxoSmithKline Company Details
Table 75. GlaxoSmithKline Business Overview
Table 76. GlaxoSmithKline Lung Cancer Therapeutics Product
Table 77. GlaxoSmithKline Revenue in Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 78. GlaxoSmithKline Recent Developments
Table 79. Roche Company Details
Table 80. Roche Business Overview
Table 81. Roche Lung Cancer Therapeutics Product
Table 82. Roche Revenue in Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 83. Roche Recent Developments
Table 84. Boehringer Ingelheim GmbH Company Details
Table 85. Boehringer Ingelheim GmbH Business Overview
Table 86. Boehringer Ingelheim GmbH Lung Cancer Therapeutics Product
Table 87. Boehringer Ingelheim GmbH Revenue in Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 88. Boehringer Ingelheim GmbH Recent Developments
Table 89. Pfizer Company Details
Table 90. Pfizer Business Overview
Table 91. Pfizer Lung Cancer Therapeutics Product
Table 92. Pfizer Revenue in Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 93. Pfizer Recent Developments
Table 94. Sanofi S.A. Company Details
Table 95. Sanofi S.A. Business Overview
Table 96. Sanofi S.A. Lung Cancer Therapeutics Product
Table 97. Sanofi S.A. Revenue in Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 98. Sanofi S.A. Recent Developments
Table 99. Bristol-Myers Squibb Company Details
Table 100. Bristol-Myers Squibb Business Overview
Table 101. Bristol-Myers Squibb Lung Cancer Therapeutics Product
Table 102. Bristol-Myers Squibb Revenue in Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 103. Bristol-Myers Squibb Recent Developments
Table 104. Novartis Company Details
Table 105. Novartis Business Overview
Table 106. Novartis Lung Cancer Therapeutics Product
Table 107. Novartis Revenue in Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 108. Novartis Recent Developments
Table 109. Agennix AG Company Details
Table 110. Agennix AG Business Overview
Table 111. Agennix AG Lung Cancer Therapeutics Product
Table 112. Agennix AG Revenue in Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
Table 113. Agennix AG Recent Developments
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Lung Cancer Therapeutics Market Share by Type: 2021 VS 2028
Figure 2. Targeted Therapy Features
Figure 3. Immunotherapy Features
Figure 4. Chemotherapy Features
Figure 5. Radiation Therapy Features
Figure 6. Others Features
Figure 7. Global Lung Cancer Therapeutics Market Share by Application: 2021 VS 2028
Figure 8. Non-Small Cell Lung Cancer (NSCLC) Case Studies
Figure 9. Small Cell Lung Cancer (SCLC) Case Studies
Figure 10. Lung Cancer Therapeutics Report Years Considered
Figure 11. Global Lung Cancer Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Lung Cancer Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Lung Cancer Therapeutics Market Share by Region: 2021 VS 2028
Figure 14. Global Lung Cancer Therapeutics Market Share by Players in 2021
Figure 15. Global Top Lung Cancer Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Therapeutics as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Lung Cancer Therapeutics Revenue in 2021
Figure 17. North America Lung Cancer Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 18. North America Lung Cancer Therapeutics Market Size Market Share by Type (2017-2028)
Figure 19. North America Lung Cancer Therapeutics Market Size Market Share by Application (2017-2028)
Figure 20. North America Lung Cancer Therapeutics Market Size Share by Country (2017-2028)
Figure 21. United States Lung Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Lung Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Lung Cancer Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 24. Europe Lung Cancer Therapeutics Market Size Market Share by Type (2017-2028)
Figure 25. Europe Lung Cancer Therapeutics Market Size Market Share by Application (2017-2028)
Figure 26. Europe Lung Cancer Therapeutics Market Size Share by Country (2017-2028)
Figure 27. Germany Lung Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France Lung Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. Lung Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy Lung Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia Lung Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries Lung Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Lung Cancer Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Asia Pacific Lung Cancer Therapeutics Market Size Market Share by Type (2017-2028)
Figure 35. Asia Pacific Lung Cancer Therapeutics Market Size Market Share by Application (2017-2028)
Figure 36. Asia Pacific Lung Cancer Therapeutics Market Size Share by Region (2017-2028)
Figure 37. China Lung Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan Lung Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea Lung Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia Lung Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India Lung Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia Lung Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 43. Latin America Lung Cancer Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Latin America Lung Cancer Therapeutics Market Size Market Share by Type (2017-2028)
Figure 45. Latin America Lung Cancer Therapeutics Market Size Market Share by Application (2017-2028)
Figure 46. Latin America Lung Cancer Therapeutics Market Size Share by Country (2017-2028)
Figure 47. Mexico Lung Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil Lung Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Lung Cancer Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Middle East and Africa Lung Cancer Therapeutics Market Size Market Share by Type (2017-2028)
Figure 51. Middle East and Africa Lung Cancer Therapeutics Market Size Market Share by Application (2017-2028)
Figure 52. Middle East and Africa Lung Cancer Therapeutics Market Size Share by Country (2017-2028)
Figure 53. Turkey Lung Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Lung Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. UAE Lung Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. AstraZeneca Revenue Growth Rate in Lung Cancer Therapeutics Business (2017-2022)
Figure 57. Eli Lilly and Company Revenue Growth Rate in Lung Cancer Therapeutics Business (2017-2022)
Figure 58. GlaxoSmithKline Revenue Growth Rate in Lung Cancer Therapeutics Business (2017-2022)
Figure 59. Roche Revenue Growth Rate in Lung Cancer Therapeutics Business (2017-2022)
Figure 60. Boehringer Ingelheim GmbH Revenue Growth Rate in Lung Cancer Therapeutics Business (2017-2022)
Figure 61. Pfizer Revenue Growth Rate in Lung Cancer Therapeutics Business (2017-2022)
Figure 62. Sanofi S.A. Revenue Growth Rate in Lung Cancer Therapeutics Business (2017-2022)
Figure 63. Bristol-Myers Squibb Revenue Growth Rate in Lung Cancer Therapeutics Business (2017-2022)
Figure 64. Novartis Revenue Growth Rate in Lung Cancer Therapeutics Business (2017-2022)
Figure 65. Agennix AG Revenue Growth Rate in Lung Cancer Therapeutics Business (2017-2022)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount